Published in J Clin Invest on August 15, 1996
Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest (2005) 2.07
Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest (1998) 1.54
Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J Clin Invest (2000) 1.24
CD8(+) T cell-mediated injury in vivo progresses in the absence of effector T cells. J Exp Med (2001) 1.02
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donors. PLoS One (2011) 0.91
Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury. Mol Immunol (2009) 0.86
Interference with intraepithelial TNF-α signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infection. Viral Immunol (2010) 0.80
Influenza lung injury: mechanisms and therapeutic opportunities. Am J Physiol Lung Cell Mol Physiol (2015) 0.75
CpG-ODN Facilitates Effective Intratracheal Immunization and Recall of Memory against Neoantigen-Expressing Alveolar Cells. Front Immunol (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
T cell tolerance by clonal elimination in the thymus. Cell (1987) 13.83
Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature (1988) 11.55
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49
In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med (1984) 6.27
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med (1986) 5.11
Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell (1991) 4.38
Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A (1994) 4.06
T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (1988) 4.04
Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes. Cell Immunol (1977) 3.60
Negative selection of lymphocytes. Cell (1994) 3.47
Immunity to influenza in man. Annu Rev Microbiol (1983) 3.22
Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med (1993) 2.88
The immune response to influenza infection. Curr Top Microbiol Immunol (1986) 2.83
Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes. J Exp Med (1981) 2.71
Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol Rev (1987) 2.64
Characteristics of the tyrosine recognition signal for internalization of transmembrane surface glycoproteins. J Cell Biol (1990) 2.20
Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A (1990) 2.08
Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or -incompatible thymus grafts. J Exp Med (1980) 1.96
Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur J Immunol (1992) 1.83
Self-ignorance in the peripheral T-cell pool. Immunol Rev (1993) 1.73
Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc Natl Acad Sci U S A (1989) 1.68
Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc Natl Acad Sci U S A (1990) 1.54
Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med (1985) 1.46
Lymphocyte recruitment to the lung. Am Rev Respir Dis (1990) 1.37
Antigen form influences induction and frequency of influenza-specific class I and class II MHC-restricted cytolytic T lymphocytes. J Immunol (1988) 1.35
Fine specificity and antigen receptor expression among influenza virus-specific cytolytic T lymphocyte clones. J Immunol (1986) 1.29
Peripheral tolerance as a multi-step mechanism. Immunol Rev (1993) 1.27
Structure and expression of the pulmonary surfactant protein SP-C gene in the mouse. J Biol Chem (1990) 1.14
Class I major histocompatibility complex-restricted T lymphocyte recognition of the influenza hemagglutinin. Overlap between class I cytotoxic T lymphocytes and antibody sites. J Exp Med (1989) 1.11
A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes. J Exp Med (1989) 1.09
In situ hybridization analysis of lymphoproliferative disorders. Assessment of clonality by immunoglobulin light-chain messenger RNA expression. Diagn Mol Pathol (1994) 1.08
A transgenic approach to the study of peripheral T-cell tolerance. Immunol Rev (1991) 1.03
Immunology: questions of presentation. Nature (1990) 1.03
Characteristics of the internalization signal in the Y543 influenza virus hemagglutinin suggest a model for recognition of internalization signals containing tyrosine. J Biol Chem (1994) 0.97
Recognition of the influenza hemagglutinin by class II MHC-restricted T lymphocytes and antibodies. I. Site definition and implications for antigen presentation and T lymphocyte recognition. J Immunol (1991) 0.94
Analysis of the humoral immune response to influenza virus in vitro. J Immunol (1976) 0.92
Our immune defence against influenza. Biochem Soc Trans (1980) 0.91
Viral antigen presentation and MHC assembly. Semin Immunol (1992) 0.87
Distinguishable pathways of viral antigen presentation to T lymphocytes. Immunol Res (1986) 0.85
The cell-mediated and humoral responses to influenza virus infection in the mouse lung. Adv Exp Med Biol (1987) 0.79
T-lymphocyte recognition of a membrane glycoprotein. Cold Spring Harb Symp Quant Biol (1989) 0.77
In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med (1984) 6.27
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev (2001) 5.67
Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones. J Exp Med (1986) 5.11
Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science (1994) 4.81
A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med (2001) 4.68
Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem (2000) 3.95
Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes. Cell Immunol (1977) 3.60
GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity (2001) 3.13
Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A (1995) 3.08
Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med (1993) 2.88
Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci U S A (1992) 2.86
Transcriptional elements from the human SP-C gene direct expression in the primordial respiratory epithelium of transgenic mice. Dev Biol (1993) 2.79
The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol (1994) 2.76
Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci U S A (1993) 2.74
Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes. J Exp Med (1981) 2.71
Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J (1993) 2.69
Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells. J Exp Med (1977) 2.68
Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med (1997) 2.67
In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma. Hum Pathol (1986) 2.56
Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J Exp Med (1994) 2.53
Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest (1996) 2.49
Human T-cell lymphotropic virus type III infection of the central nervous system. A preliminary in situ analysis. JAMA (1986) 2.48
Gene structure and expression of human thyroid transcription factor-1 in respiratory epithelial cells. J Biol Chem (1995) 2.43
Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med (1997) 2.40
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A (2000) 2.32
Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A (1996) 2.29
Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest (2000) 2.25
Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR. Science (1994) 2.24
Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med (1999) 2.20
Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest (1995) 2.20
Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem (1992) 2.18
cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J Biol Chem (1992) 2.18
Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol (1999) 2.13
Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol (2000) 2.12
FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol (2001) 2.12
Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest (1991) 2.11
Cytotoxic T lymphocyte recognition of the influenza hemagglutinin gene product expressed by DNA-mediated gene transfer. J Exp Med (1984) 2.10
Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem (1996) 2.03
Expression of a murine polyclonal T cell receptor marker correlates with the use of specific members of the V beta 8 gene segment subfamily. J Exp Med (1987) 1.96
Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest (1994) 1.96
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol (1998) 1.92
Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet (1988) 1.92
Role of viral infectivity in the induction of influenza virus-specific cytotoxic T cells. J Exp Med (1978) 1.91
Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol (1996) 1.90
Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res (1992) 1.86
Transient induction of TGF-alpha disrupts lung morphogenesis, causing pulmonary disease in adulthood. Am J Physiol Lung Cell Mol Physiol (2004) 1.84
The analysis of the monoclonal immune response to influenza virus. I. Production of monoclonal anti-viral antibodies in vitro. Eur J Immunol (1975) 1.81
Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol (2001) 1.79
Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem (1998) 1.77
Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol (1997) 1.77
Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest (1999) 1.77
Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message. J Clin Oncol (2001) 1.76
Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol (1999) 1.75
Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J (1991) 1.73
Genetic element from human surfactant protein SP-C gene confers bronchiolar-alveolar cell specificity in transgenic mice. Am J Physiol (1991) 1.72
Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum Pathol (1994) 1.72
Expression of thyroid transcription factor-1(TTF-1) in fetal and neonatal human lung. J Histochem Cytochem (1996) 1.69
Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity (2001) 1.69
Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci U S A (2001) 1.68
Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells. Nature (1989) 1.67
Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. Dev Biol (1996) 1.65
Specificity of cytotoxicity T cells directed to influenza virus hemagglutinin. J Exp Med (1979) 1.64
Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B. DNA (1989) 1.63
Consensus conference on second opinions in diagnostic anatomic pathology. Who, What, and When. Am J Clin Pathol (2000) 1.60
GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest (1999) 1.59
Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor. Dev Biol (2001) 1.59
An atypical subcutaneous infection associated with acquired immune deficiency syndrome. Am J Clin Pathol (1983) 1.59
On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes. J Exp Med (1987) 1.58
Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem (1994) 1.58
Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem (1995) 1.58
cDNA and deduced amino acid sequence of human pulmonary surfactant-associated proteolipid SPL(Phe). Proc Natl Acad Sci U S A (1987) 1.58
Role of T-cell function in recovery from murine influenza infection. Cell Immunol (1979) 1.57
Tumor progression and cellular differentiation of pulmonary adenocarcinomas in SV40 large T antigen transgenic mice. Am J Respir Cell Mol Biol (1997) 1.55
Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol (1995) 1.55
Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res (1990) 1.55
Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc Natl Acad Sci U S A (1990) 1.54
Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest (1998) 1.54
Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg (1994) 1.54
Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr (1998) 1.53
Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol (1998) 1.52
Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice. J Immunol (2000) 1.52
The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses. J Immunol (2000) 1.50
Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products. Cell Immunol (1984) 1.50
Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol (1985) (1987) 1.50
Molecular mechanisms controlling lung morphogenesis. Clin Genet (1999) 1.49
Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection. J Virol (1997) 1.48
Isolated extragenital HPV-thirties-group-positive bowenoid papulosis in an AIDS patient. Br J Dermatol (1994) 1.47
VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn (1998) 1.47
Surfactant protein D regulates NF-kappa B and matrix metalloproteinase production in alveolar macrophages via oxidant-sensitive pathways. J Immunol (2001) 1.46
Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med (1985) 1.46
SP-A deficiency in primate model of bronchopulmonary dysplasia with infection. In situ mRNA and immunostains. Am J Respir Crit Care Med (1995) 1.46
Surfactant metabolism in transgenic mice after granulocyte macrophage-colony stimulating factor ablation. Am J Physiol (1996) 1.46
Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol (2000) 1.45
The lung-specific CC10 gene is regulated by transcription factors from the AP-1, octamer, and hepatocyte nuclear factor 3 families. Mol Cell Biol (1993) 1.44
Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med (2000) 1.42
Clara cell secretory protein decreases lung inflammation after acute virus infection. Am J Physiol (1998) 1.39
Pulmonary collectins and innate host defense of the lung. Microbes Infect (2001) 1.39
Chairpersons of pathology in the United States. Benchmarks for academic publications and professional credentials. Am J Clin Pathol (2001) 1.39
Surfactant protein deficiency in familial interstitial lung disease. J Pediatr (2001) 1.37